t
penetration of its drug products, to the development and commercialization
of its pipeline products and to its expectations in connection with any
future event, condition, performance or other matter, are forward-looking
and are made pursuant to the safe harbor provisions of the Securities
Litigation Reform Act of 1995. Such statements involve risks and
uncertainties that may cause results to differ materially from those set
forth in these statements. Additional economic, competitive, governmental,
technological, marketing and other factors identified in Pharmos' filings
with the Securities and Exchange Commission could affect such results.
PHARMOS CORPORATION
Consolidated Statements of Operations
For the three months ended For the year ended
Dec. 31, 2007 Dec. 31, 2006 Dec. 31, 2007 Dec. 31, 2006
Expenses
Research &
development,
gross $2,172,023 $2,369,341 $11,457,566 $8,956,821
Grants (42,970) (362,049) (812,042) (1,445,513)
Research &
development,
net of grants 2,129,053 2,007,292 10,645,524 7,511,308
In-process
acquired
research and
development - 20,607,575 - 20,607,575
General &
administrative 1,699,876 2,070,260 6,698,601 9,108,867
Depreciation and
amortization 40,553 72,857 235,134 314,769
Total operating
expenses 3,869,482 24,757,984 17,579,259 37,542,519
Loss from
operations (3,869,482) (24,757,984) (17,579,259) (37,542,519)
Other income
(expense)
Interest income 156,166 370,805 938,312 1,778,042
Interest expense - - - -
Change in value o
'/>"/>
SOURCE Pharmos Corporation Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 Related medicine news :1.
Pharmos Restructures Operations in Israel2.
National Atlantic Holdings Corporation to Report Fourth Quarter and Year-End 2007 Earnings on March 17, 20083.
Linkwell Corporations Skin Disinfectant Product Chosen for 2008 Beijing Olympic Games4.
Partners Center for Connected Health and EMC Corporation Launch New Web-Based Remote Monitoring Program to Help Employees Fight Hypertension5.
China Bionanometer Industries Corporation Announces New Products for China6.
Centene Corporation Unveils Winners of the 2008 Physician Summit Award7.
Dialysis Corporation of America Announces its Newest Center Opening in South Carolina8.
Harris Corporation Demonstrates Digital Signage(TM) Solutions for Dynamic, Rapid Communications within Healthcare Enterprises9.
Harris Corporation Unveils Broadcast-Style Multiviewers for Real-Time Multi- Screen Access to Medical Information10.
Harris Corporation Demonstrates Remote Digital Imagery Display and Manipulation for Pathology Applications11.
Cerner Corporation and Hill-Rom Partner to Unify Hospital Care Delivery